Back to HomeBeta

ICD-10 Coding for Peritoneal Carcinomatosis(C78.6, C48.2)

Complete ICD-10-CM coding and documentation guide for Peritoneal Carcinomatosis. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Peritoneal MetastasisSecondary Peritoneal Cancercarcinomatosis peritoneal

Related ICD-10 Code Ranges

Complete code families applicable to Peritoneal Carcinomatosis

C78-C79Primary Range

Secondary malignant neoplasms

This range includes codes for secondary malignant neoplasms, including peritoneal carcinomatosis.

Malignant neoplasm of retroperitoneum and peritoneum

This range includes codes for primary malignant neoplasms of the peritoneum.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C78.6Secondary malignant neoplasm of retroperitoneum and peritoneumUse when peritoneal carcinomatosis is secondary to another primary cancer.
  • Imaging showing peritoneal nodules or omental caking
  • Biopsy confirming metastasis
  • Documentation of primary cancer site
C48.2Malignant neoplasm of peritoneum, unspecifiedUse when primary peritoneal cancer is diagnosed without a known primary elsewhere.
  • Histological confirmation of primary peritoneal origin
  • Immunohistochemistry consistent with primary peritoneal cancer

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for peritoneal carcinomatosis

Essential facts and insights about Peritoneal Carcinomatosis

The ICD-10 code for peritoneal carcinomatosis is C78.6, used for secondary malignant neoplasms of the peritoneum.

Primary ICD-10-CM Codes for peritoneal carcinomatosis

Secondary malignant neoplasm of retroperitoneum and peritoneum
Billable Code

Decision Criteria

clinical Criteria

  • Presence of peritoneal nodules on imaging

documentation Criteria

  • Biopsy confirming metastatic adenocarcinoma

Applicable To

  • Metastatic peritoneal cancer

Excludes

  • Primary peritoneal cancer (C48.2)

Clinical Validation Requirements

  • Imaging showing peritoneal nodules or omental caking
  • Biopsy confirming metastasis
  • Documentation of primary cancer site

Code-Specific Risks

  • Incorrectly coding as primary peritoneal cancer

Coding Notes

  • Ensure primary cancer site is documented and coded first.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Other ascites

R18.8
Use if ascites is present and clinically significant.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of peritoneum, unspecified

C48.2
Use C48.2 only for primary peritoneal cancer, not for metastatic disease.

Secondary malignant neoplasm of retroperitoneum and peritoneum

C78.6
Use C78.6 for metastatic peritoneal involvement from another primary site.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Peritoneal Carcinomatosis to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C78.6.

Impact

Clinical: Misguides treatment planning., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.

Mitigation Strategy

Cross-reference with oncology records., Ensure comprehensive history taking.

Impact

Reimbursement: Incorrect reimbursement due to misclassification., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate cancer registry data.

Mitigation Strategy

Verify and document the primary cancer site before coding.

Impact

Misclassification can lead to audit flags.

Mitigation Strategy

Thorough documentation and verification of primary cancer sites.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Peritoneal Carcinomatosis, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Peritoneal Carcinomatosis

Use these documentation templates to ensure complete and accurate documentation for Peritoneal Carcinomatosis. These templates include all required elements for proper coding and billing.

Oncology Progress Note

Specialty: Oncology

Required Elements

  • History of present illness
  • Imaging findings
  • Biopsy results
  • Treatment plan

Example Documentation

63F with history of gastric adenocarcinoma (C16.9) presents with progression to peritoneal carcinomatosis. PET/CT shows hypermetabolic peritoneal nodules (SUVmax 8.7). Paracentesis yielded 2L bloody fluid; cytology positive for signet-ring cells. Plan: Initiate HIPEC.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Peritoneal involvement noted.
Good Documentation Example
Diffuse peritoneal carcinomatosis secondary to stage IV serous ovarian adenocarcinoma (C56.2), confirmed via laparoscopic biopsy. Ascites >1000ml present.
Explanation
The good example specifies the primary cancer, confirms diagnosis with biopsy, and quantifies ascites.

Need help with ICD-10 coding for Peritoneal Carcinomatosis? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more